Dr. Daniel S. Berman[email protected]Nuclear MedicineScreening for CAD in diabetics: Which patient? Which test?Screening for coronary artery disease (CAD) in any population is controversial. In this editorial opinion, Dr. Daniel Berman of Cedars-Sinai Medical Center points out what he believes are shortcomings in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study published this week in the Journal of the American Medical Association.April 16, 2009Page 1 of 1Top StoriesPractice ManagementNew MR safety codes provide additional reimbursement for radiologistsIn a new column, Erin Stephens of Healthcare Administrative Partners reviews the new CPT code changes for MR safety services.CTCT, MRI reveal hidden brain changes linked to increased fall riskWomens ImagingImaging societies, experts react to U.S. Supreme Court's ruling on Braidwood caseMRIDeep learning plus MRI predicts likelihood of postpartum hemorrhageWomens ImagingPersonal tragedies spur unity behind bill for diagnostic breast care